Showing results (371-380 of 2,398) with videos related to
Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|January 14, 2020
Postoperative radiotherapy-induced leiomyosarcoma in breast cancer: a case report and literature reviewYong Liu, Jiaming Wang, Rong Su, et al.Breast Cancer (Tokyo, Japan)|January 15, 2020
Fat necrosis in level I oncoplastic breast-conserving surgery focusing on a modified round block techniqueHisamitsu Zaha, Tokiwa Motonari, Norie Abe, et al.Breast Cancer (Tokyo, Japan)|January 15, 2020
The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancerRisa Goto, Yuko Hirota, Tomoyuki Aruga, et al.Breast Cancer (Tokyo, Japan)|November 13, 2020
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese womenKengo Kawada, Naruto Taira, Taeko Mizoo, et al.Breast Cancer (Tokyo, Japan)|September 8, 2020
Correction to: Letter to the Editor: comment on 'Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective' by Elfgen et alIoanna Akrida, Maria-Ioanna ArgentouBreast Cancer (Tokyo, Japan)|November 4, 2020
A novel immune-related prognostic index for predicting breast cancer overall survivalXiaosi Yu, Juan Guo, Qian Zhou, et al.Breast Cancer (Tokyo, Japan)|February 16, 2020
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01Hiroyasu Yamashiro, Hiroji Iwata, Norikazu Masuda, et al.Breast Cancer (Tokyo, Japan)|February 29, 2020
Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancerMayu Myojin, Yoshiya Horimoto, Mayuko Ito, et al.Breast Cancer (Tokyo, Japan)|March 7, 2020
Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire surveyYuka Goto, Koichiro Tsugawa, Yuko Furuya, et al.Breast Cancer (Tokyo, Japan)|December 14, 2018
Toll-like receptor 4 and breast cancer: an updated systematic reviewMorteza Khademalhosseini, Mohammad Kazemi ArababadiPageof 240